Try our mobile app

S.Africa`s Aspen seeks licence for J&J COVID shot as EU shipments halted

Published: 2021-09-02 tag: healthcare and pharmaceuticals

JSE:APN JSE:AVI

JOHANNESBURG, Sept 2 (Reuters) - (Withdraws alert and story issued in error)

An alert and story on Sept. 2 saying South Africa's Aspen Pharmacare is in talks with Johnson & Johnson <JNJ.N> relating to the manufacturing of a COVID-19 vaccine is withdrawn. The alert and story related to a December 2020 presentation and were issued in error. A substitute story will follow.